Effect of Diet on Gulf War Illness

NCT ID: NCT02881944

Last Updated: 2018-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fermentable Oligo-, Di and Mono-saccharides And Polyols (FODMAPs) are carbohydrates that are poorly digested in intestines. The undigested carbohydrates are fermented in the colon by gut bacteria. Fermentation of these carbohydrates can lead to diarrhea, gas and distension of the colon. Low FODMAP diet effect may be mediated by changing the gut bacteria and/or by production of chemicals that influence Veteran's intestines which then result in reduced disease symptoms.

The goal of this study is to compare a low FODMAP (modified healthy) diet to a high FODMAP (typical healthy) diet for effect on Veterans with IBS and symptoms of Gulf War illness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design This will be a prospective, blinded randomized clinical trial with two parallel groups. There will be 1-week screening period, 3-week diet treatment and, follow-up one month later while Veterans choose their own diet.

Veterans who were deployed and served in Operation Desert Storm and Desert Shield will be recruited to participate.

The two study diets to be provided to the Veterans and compared are:

Low FODMAP (modified healthy) diet:

High FODMAP (typical healthy) diet:

The FODMAP content of this diet will be higher than low FODMAP diet.

All questionnaires will be answered and measurements performed at baseline, end of treatment and at follow-up visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low FODMAP (modified healthy) Diet

Low FODMAP diet for 3 weeks. Veterans will be provided a diet containing foods low in FODMAP.

Group Type EXPERIMENTAL

Low FODMAP Diet

Intervention Type BEHAVIORAL

Diet low in foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols

High FODMAP (typical healthy) Diet

High FODMAP diet for 3 weeks. Veterans will be provided a typically healthy diet following US Dietary Guidelines, containing foods high in FODMAPs

Group Type EXPERIMENTAL

High FODMAP Diet

Intervention Type BEHAVIORAL

Typical diet of foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low FODMAP Diet

Diet low in foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols

Intervention Type BEHAVIORAL

High FODMAP Diet

Typical diet of foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gulf War Veterans
* Men and women age 25-90 years
* Gulf War Illness: Veterans will have Rome III criteria for IBS and two or more of the non-intestinal symptom groups (chronic-once a week or more often-fatigue, insomnia, joint pains, general stiffness, and headache, neurological an mood, respirator and skin symptoms)
* Symptoms of \> 6 months duration
* No significant findings on physical examination, complete blood count and clinical chemistry panel

Exclusion Criteria

* Veterans with psychological disorders will not be excluded but will be identified for sub-group analysis.


* Current evidence of any lower gastrointestinal disorder such as celiac disease or inflammatory bowel disease
* Clinically significant chronic disease: HIV, cardiac, pulmonary, hepatic or renal dysfunction
* Presence of Giardia antigen, and Clostridium difficile toxin in stool
* Current history of drug or alcohol abuse
* Investigator perception of patient's inability to comply with study protocol
* Recent change in gastrointestinal medications
* Subject is currently participating in another research protocol. These subjects will be allowed to enroll after a washout period of one month.
Minimum Eligible Age

25 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Defense

FED

Sponsor Role collaborator

Ashok Tuteja

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ashok Tuteja

Professor Gastroenterology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ashok K Tuteja, M.D.

Role: PRINCIPAL_INVESTIGATOR

George E. Wahlen VA Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

George E Wahlen VA Medical Center

Salt Lake City, Utah, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jaya Vijayan, MBBS

Role: CONTACT

801-582-1565 ext. 4019

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ashok K Tuteja, MD, MPH

Role: primary

801-582-1565 ext. 4019

Jaya Vijayan

Role: backup

801-581-7802

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB_00087668

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanisms of Gulf War Illness
NCT05972291 RECRUITING NA